☆ 3.8 Editorial Material

Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme

NATURE CLINICAL PRACTICE ONCOLOGY (2008)

Get Full Text
Add to Collection

Journal

NATURE CLINICAL PRACTICE ONCOLOGY
Volume 5, Issue 4, Pages 186-187

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncponc1077

Keywords

bevacizumab; glioblastoma multiforme; irinotecan; survival; toxicity

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.